Life Sciences Newsletter – April 2023

LIFE SCIENCES NEWSLETTER

DIGESA

 

FOOD – HEALTH REGISTRATION

DIGESA communicated through its website details on the application for health registration of foodstuffs:

1. It must not declare substances that have therapeutic effect.
2. It must not contain statements that “indicate, represent, suggest or imply that the product is useful, suitable or effective to prevent, alleviate, treat or cure any disease or physiological disorder.
3. Any substance and/or ingredient to be used must be covered by national and international reference standards.

HOUSEHOLD HYGIENE PRODUCTS WITH DISINFECTANT ACTION

Ministerial Resolution Nº 106-2023-MINCETUR approved the incorporation of three (3) DIGESA services, to be incorporated through the Foreign Trade Single Window (VUCE):

Mandatory Health Notification – NSO

Recognition of the NSO

Renewal of the NSO

DIGEMID

 

PRODUCTS NOT SUBJECT TO HEALTH REGISTRATION

DIGEMID published in its website the updated list of products that do not require health registration.

The list contains 1437 items.

THE LIST OF MODELING SUBSTANCES WAS PUBLISHED

Ministerial Resolution Nº 376-2023/MINSA approved the list of modeling substances in the framework of the provisions of Article 7 of Law N° 31014, Law that regulates the use of modeling substances in body treatments for aesthetic purposes and defines such procedure as a medical act.

Modeling substances are those injectable filler substances or biopolymers, polymers and related resorbable, biodegradable or permanent, used in body treatments for aesthetic purposes.

PHARMACEUTICAL PRODUCTS – AMENDING ACTS

The DIGEMID communicated through its website that the directorial resolutions that resolve to modify the health registration of pharmaceutical products for safety reasons will be notified in the e-mails of the holders of health registration registered in the DIGEMID.

SENASA

 

87% OF FOODS ANALYZED DO NOT REPRESENT A HEALTH RISK

The National Agricultural Health Service (SENASA) presented the results of the 2022 agricultural food monitoring plan, in which a total of 9,250 food samples were analyzed and 87.82% of them were found not to represent a health risk to consumers.

SENASA is formulating a new public investment project with the IDB to continue improving health surveillance at the national level.

MINSA

 

CLINICAL PRACTICE GUIDELINE FOR DIABETES MELLITUS

Ministerial Resolution Nº 289-2023/MINSA approved the Technical Guide: Clinical Practice Guideline for the Diagnosis and Treatment of Non Insulin Dependent Diabetes Mellitus (Type 2) with Ketoacidosis, Hyperglyce.